Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 17Unknown 6Recruiting 6Terminated 5Active not recruiting 4Withdrawn 3Enrolling by invitation 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Neoplasms 3Papillomavirus Infections 3HIV Infections 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Colposcopy × Clear all
NCT06498661 2026-05-13

SHIP-A-S01

National Cancer Institute (NCI)

Phase NA Active not recruiting
750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting
1,586 enrolled

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡